SAGENT PHARMACEUTICALS INC's ticker is SGNT and the CUSIP is 786692103. A total of 103 filers reported holding SAGENT PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $28,951,000 | +23.5% | 1,932,683 | +0.4% | 0.00% | 0.0% |
| Q1 2016 | $23,437,000 | -16.1% | 1,925,770 | +9.6% | 0.00% | 0.0% |
| Q4 2015 | $27,949,000 | +7.4% | 1,756,675 | +3.5% | 0.00% | +100.0% |
| Q3 2015 | $26,028,000 | -36.3% | 1,697,853 | +0.9% | 0.00% | -66.7% |
| Q2 2015 | $40,888,000 | +4.1% | 1,681,932 | -0.4% | 0.00% | 0.0% |
| Q1 2015 | $39,274,000 | -2.4% | 1,689,195 | +5.5% | 0.00% | 0.0% |
| Q4 2014 | $40,220,000 | -12.9% | 1,601,727 | +7.9% | 0.00% | -25.0% |
| Q3 2014 | $46,167,000 | +38.4% | 1,484,501 | +15.1% | 0.00% | +33.3% |
| Q2 2014 | $33,357,000 | +11.7% | 1,289,922 | +0.9% | 0.00% | 0.0% |
| Q1 2014 | $29,876,000 | +0.5% | 1,278,365 | +9.1% | 0.00% | 0.0% |
| Q4 2013 | $29,737,000 | +36.1% | 1,171,639 | +9.4% | 0.00% | +50.0% |
| Q3 2013 | $21,842,000 | +53.0% | 1,070,692 | +57.3% | 0.00% | +100.0% |
| Q2 2013 | $14,276,000 | – | 680,473 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|